Detection of COVID-19 Using Breath Analysis - Validation Study
NCT ID: NCT04602949
Last Updated: 2023-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2558 participants
INTERVENTIONAL
2020-11-12
2023-01-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of COVID-19 Using Breath Analysis - Validation Study.
NCT05224622
Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis
NCT04842708
Detection of Bacterial and Viral Pathogens Infection Among Hospitalized Patients Feasibility Study
NCT05399615
SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem
NCT04497610
COVID Breath Test - Ancon
NCT04760639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary objective- To validate the value of a set of breath VOC biomarkers that enable us to distinguish between Coronavirus (SARS-CoV-2) carriers and SARS-CoV-2-negative in comparison to the gold-standard testing methodology.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 patients
subjects who were found as COVID-19 positive patients by swab RT-PCR
Breath Biopsy Analysis
Analysis of a single breath Biopsy
Healthy controls
subjects who were found as COVID-19 Negative, by swab RT-PCR
Breath Biopsy Analysis
Analysis of a single breath Biopsy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breath Biopsy Analysis
Analysis of a single breath Biopsy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of understanding written and/or spoken language
* Able to provide informed consent
* Was not treated with Anti-viral drugs
Exclusion Criteria
* Under guardianship or deprived of liberty
* Pregnant or lactating woman
6 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Scentech Medical Technologies Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Natalie Dror, PhD
Role: STUDY_DIRECTOR
Scentech Medical Technologies Ltd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shamir Medical Center
Be’er Ya‘aqov, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cov-2-SMC-2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.